Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 26 (4) , 499-527
- https://doi.org/10.1016/s0149-7634(02)00017-9
Abstract
No abstract availableKeywords
This publication has 254 references indexed in Scilit:
- Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1)Biochemical and Biophysical Research Communications, 1996
- Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeuticsLife Sciences, 1995
- NE-100, a novel sigma receptor ligand: Effect on phencyclidine-induced behaviors in rats, dogs and monkeysLife Sciences, 1994
- BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Supersensitivity of σ receptors after repeated administration of cocaineLife Sciences, 1992
- Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disordersLife Sciences, 1990
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989
- Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexusLife Sciences, 1988
- Ascorbic acid and striatal transport of [3H]1-methyl-4-phenylpyridine (MPP+) and [3H]dopamineLife Sciences, 1988
- Drug-environment interaction: Context dependency of cocaine-induced behavioral sensitizationLife Sciences, 1981